Medicare Advantage COVID Treatment Act

Bill Number

HR 6640

Introduced

Apr 28, 2020

Latest Action

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be ...

Sponsor

Cosponsors

Topics

Cardiovascular and respiratory health Emergency medical services and trauma care Health Health care costs and insurance Health care coverage and access Hospital care Infectious and parasitic diseases Medicare

Full Text

View Full Bill Text

Votes

Summary

Medicare Advantage COVID Treatment Act

This bill requires Medicare Advantage (MA) plans to cover specified treatment services relating to COVID-19 (i.e., coronavirus disease 2019) without cost-sharing during the public health emergency declared on January 31, 2020. The CMS must reimburse MA plans for cost-sharing amounts that would otherwise have been received, in accordance with a specified timeline.

MA plans are also prohibited from instituting prior authorization or other utilization management requirements with respect to coverage of specified critical treatment services (e.g., ventilator services and intensive care unit services).

Actions

Apr 28, 2020

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 28, 2020

Introduced in House

Amendments

Related Bills